Probiotics may tame nausea and diarrhea from popular obesity medications
NCT ID NCT07213323
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests whether taking probiotics can reduce common stomach issues like nausea, diarrhea, and abdominal pain caused by GLP-1 weight-loss drugs (semaglutide or tirzepatide). About 50 adults with obesity starting these medications will receive either probiotics or a placebo for 24 weeks. The goal is to see if probiotics help people tolerate higher doses and stick with treatment, improving their digestive quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Lyon Sud
Pierre-Bénite, 69495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.